Locus Biosciences, Inc. services

With an eye on servicing healthcare markets globally, we built a 10,000 sq ft modular facility that can meet the standards of the US (FDA), Europe (EMA), Japan (PMDA), and several other countries and regions. The architectural layout and HVAC design ensure the robust biocontainment of organisms within the BSL-2 facility that meet all CDC, NIH, WHO, and ECDC requirements. At the heart of the facility are the three self-contained manufacturing suites: upstream, for bioreactor culture and harvest; downstream, for purification and formulation; and aseptic, for filling and finishing.

We built a world-class biologics manufacturing facility, enabling the manufacture of our precision therapeutics while providing the capability to also manufacture gene therapy vectors and other advanced biologics. Our facility design allows for parallel production of multiple drug substances simultaneously, in isolated production suites, without risk of cross-contamination. It is optimized for viral vector manufacturing, including bacteriophage, adenovirus, AAV, and other vectors. Taken together, our facility and proprietary production processes allow for all viral products manufactured by Locus to meet or exceed US and international regulatory standards for parenterally administered drug products for clinical and commercial use.